Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan · Delayed Price · Currency is JPY 2,088.00
+4.00 (0.19%)
Nov 13, 2026, 3:30 PM JST
Zeria Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 94,660 | 89,159 | 87,311 | 75,725 | 68,383 | 59,532 |
Revenue Growth | 11.56% | 2.12% | 15.30% | 10.74% | 14.87% | 7.38% |
Gross Profit Gross Profit Growth | 68,574 | 65,183 | 63,960 | 55,501 | 49,488 | 42,148 |
Operating Income Operating Income Growth | 14,381 | 12,375 | 12,198 | 9,622 | 9,015 | 6,366 |
Net Income Net Income Growth | 10,676 | 8,454 | 9,936 | 7,731 | 6,195 | 3,961 |
Earnings Per Share EPS Growth | 242.20 | 191.79 | 225.41 | 175.39 | 140.24 | 87.75 |
EPS Growth | 90.24% | -14.92% | 28.52% | 25.06% | 59.82% | 29.62% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Consumer Health Care Business Consumer Health Care Business Growth | 27,556 | 27,383 | 28,180 | 25,999 | 25,086 | 22,370 |
Other Other Growth | 611.62 | 628.72 | 698.18 | 751.17 | 657.42 | 715.07 |
Medical use Business Medical use Business Growth | 66,960 | 61,631 | 58,980 | 49,585 | 43,148 | 37,006 |
Unallocated Adjustment Unallocated Adjustment Growth | -468.43 | -482.76 | -546.56 | -610.23 | -508.12 | -558.57 |
Total Total Growth | 94,660 | 89,159 | 87,311 | 75,725 | 68,383 | 59,533 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 29,159 | 27,760 | 23,592 | 20,323 | 16,219 | 11,704 |
Total Debt Total Debt Growth | 37,014 | 39,103 | 41,163 | 46,226 | 49,431 | 52,227 |
Net Cash (Debt) Net Cash Growth | -7,855 | -11,343 | -17,571 | -25,903 | -33,212 | -40,523 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -178.20 | -257.33 | -398.62 | -587.64 | -751.86 | -897.74 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 12,207 | 9,955 | 12,922 | 12,183 | 13,157 | 8,950 |
Capital Expenditures CapEx Growth | -2,049 | -2,361 | -1,429 | -2,900 | -2,400 | -1,064 |
Free Cash Flow Free Cash Flow Growth | 10,158 | 7,594 | 11,493 | 9,283 | 10,757 | 7,886 |
Free Cash Flow Growth | 79.82% | -33.92% | 23.81% | -13.70% | 36.41% | 28.02% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 72.44% | 73.11% | 73.26% | 73.29% | 72.37% | 70.80% |
Operating Margin | 15.19% | 13.88% | 13.97% | 12.71% | 13.18% | 10.69% |
Pretax Margin | 14.51% | 12.56% | 14.45% | 12.56% | 10.63% | 9.61% |
Profit Margin | 11.28% | 9.48% | 11.38% | 10.21% | 9.06% | 6.65% |
FCF Margin | 10.73% | 8.52% | 13.16% | 12.26% | 15.73% | 13.25% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 52.000 | 49.000 | 47.000 | 44.000 | 40.000 | 35.000 |
Dividend Per Share Growth | 4.08% | 4.25% | 6.82% | 10.00% | 14.29% | 2.94% |
Dividend Yield | 2.49% | 2.28% | 2.08% | 2.06% | 1.78% | 1.82% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 8.62 | 11.19 | 10.01 | 12.16 | 15.97 | 21.54 |
Forward PE | 10.00 | 10.40 | 10.13 | 11.34 | 12.53 | 20.60 |
P/FCF Ratio | 9.06 | 12.45 | 8.66 | 10.12 | 9.20 | 10.82 |
PS Ratio | 0.97 | 1.06 | 1.14 | 1.24 | 1.45 | 1.43 |